Key Takeaways:
Insurance funds deepened their exposure to China's hard-technology sector through two landmark STAR Market IPOs, with 61 insurers subscribing to ChangXin Memory Technologies shares.
"Insurance funds choosing the LP model reflects considerations around professional capability, risk control, and asset allocation," Zhu Junsheng, a professor at Peking University, said. "Humanoid robotics involves AI, chips, and new materials, where investment requires specialized expertise."
Unitree Robotics set its IPO price at 150.80 yuan per share on Aug. 6, raising approximately 6.1 billion yuan and implying a post-listing market capitalization of about 61 billion yuan. Six insurance companies hold indirect stakes in the humanoid robot maker through three fund channels. CPIC Longhang committed 500 million yuan to Nanjing Jingwei Chuang No. 3, which directly holds 1.193 percent of Unitree; AIA Life invested 400 million yuan and MetLife 200 million yuan in the same fund. Ruize Life and New China Life hold 5.45 percent and 2.55 percent stakes in Jinshi Growth, which owns 4.152 percent of Unitree. More than 20 insurers, including China Life, PICC Life, and PICC Property & Casualty, hold indirect positions through fourth-tier shareholder structures.
ChangXin Memory Technologies, which listed July 27 with a market cap exceeding 3 trillion yuan on debut, counts six insurers among its shareholders with cumulative commitments of 2.385 billion yuan. Hexie Health holds a 1.5 percent direct stake, while Guoshou Investment and PICC Capital each hold about 0.8 percent through equity investment plans. In the strategic placement, China Life, PICC P&C, China Post Life, and Taikang Life each received approximately 11.5 million shares worth about 100 million yuan.
The April 2025 policy package from three government departments raised equity investment limits for insurers by 5 percentage points and increased the single venture capital fund investment cap to 30 percent. "Insurance capital has 20- to 30-year duration, high stability, and low redemption pressure, naturally matching the long-cycle R&D and industrialization of hard-tech companies," Wang Weiyi, an analyst at Guosheng Securities, said.
Guoshou Investment, which began investing in ChangXin in 2020 when the company was still ramping yields and far from profitability, held through the global memory downturn. ChangXin projects first-half net profit of 50 billion to 57 billion yuan, confirming the value of long-term holding, according to a company spokesperson.
Unitree's strategic placement also drew DeepSeek, which invested 140.8 million yuan for a 2.31 percent stake, and Tencent affiliate Qishan Investment. The company's IPO review took 73 days from filing to approval, the fastest on the STAR Market.
The two IPOs mark a shift in how insurance capital accesses China's technology sector. As regulators expand equity allocation headroom, insurers are expected to increase direct and indirect positions in semiconductors, robotics, and embodied intelligence. The next test will be Unitree's first-day trading, with retail subscription opening Aug. 10.
This article is for informational purposes only and does not constitute investment advice.
